Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 27016 | 24.07 |
09:34 ET | 40832 | 24.1401 |
09:36 ET | 28627 | 24.1 |
09:38 ET | 35348 | 23.97 |
09:39 ET | 23314 | 23.98 |
09:41 ET | 8717 | 23.89 |
09:43 ET | 22715 | 23.84 |
09:45 ET | 37833 | 23.74 |
09:48 ET | 18830 | 23.8 |
09:50 ET | 16255 | 23.92 |
09:52 ET | 26234 | 23.99 |
09:54 ET | 21446 | 23.85 |
09:56 ET | 23576 | 23.63 |
09:57 ET | 22119 | 23.67 |
09:59 ET | 11531 | 23.68 |
10:01 ET | 17792 | 23.65 |
10:03 ET | 7255 | 23.7 |
10:06 ET | 9260 | 23.695 |
10:08 ET | 25843 | 23.66 |
10:10 ET | 15627 | 23.745 |
10:12 ET | 10202 | 23.67 |
10:14 ET | 18322 | 23.64 |
10:15 ET | 6150 | 23.63 |
10:17 ET | 7290 | 23.635 |
10:19 ET | 12248 | 23.655 |
10:21 ET | 13822 | 23.615 |
10:24 ET | 16896 | 23.58 |
10:26 ET | 32194 | 23.495 |
10:28 ET | 16429 | 23.58 |
10:30 ET | 9370 | 23.53 |
10:32 ET | 18233 | 23.47 |
10:33 ET | 6177 | 23.5 |
10:35 ET | 10676 | 23.48 |
10:37 ET | 8696 | 23.58 |
10:39 ET | 5786 | 23.605 |
10:42 ET | 15499 | 23.61 |
10:44 ET | 8197 | 23.65 |
10:46 ET | 16387 | 23.83 |
10:48 ET | 20618 | 23.77 |
10:50 ET | 11103 | 23.76 |
10:51 ET | 15247 | 23.86 |
10:53 ET | 4558 | 23.81 |
10:55 ET | 5774 | 23.9 |
10:57 ET | 9840 | 23.875 |
11:00 ET | 6632 | 23.9 |
11:02 ET | 9903 | 23.93 |
11:04 ET | 7132 | 23.89 |
11:06 ET | 1785 | 23.82 |
11:08 ET | 4025 | 23.86 |
11:09 ET | 4228 | 23.885 |
11:11 ET | 29029 | 24.015 |
11:13 ET | 8031 | 23.94 |
11:15 ET | 3530 | 23.93 |
11:18 ET | 8500 | 24.01 |
11:20 ET | 12083 | 24.06 |
11:22 ET | 24091 | 24.1593 |
11:24 ET | 24425 | 24.215 |
11:26 ET | 19645 | 24.24 |
11:27 ET | 12258 | 24.245 |
11:29 ET | 5549 | 24.19 |
11:31 ET | 5011 | 24.16 |
11:33 ET | 5558 | 24.21 |
11:36 ET | 11346 | 24.23 |
11:38 ET | 13368 | 24.27 |
11:40 ET | 8328 | 24.31 |
11:42 ET | 12083 | 24.335 |
11:44 ET | 13609 | 24.49 |
11:45 ET | 49646 | 24.52 |
11:47 ET | 21124 | 24.52 |
11:49 ET | 12109 | 24.4505 |
11:51 ET | 5862 | 24.43 |
11:54 ET | 10134 | 24.4 |
11:56 ET | 3469 | 24.415 |
11:58 ET | 3049 | 24.39 |
12:00 ET | 8586 | 24.4 |
12:02 ET | 16850 | 24.4 |
12:03 ET | 13455 | 24.41 |
12:05 ET | 7509 | 24.504 |
12:07 ET | 40932 | 24.67 |
12:09 ET | 24422 | 24.8 |
12:12 ET | 31177 | 24.72 |
12:14 ET | 52165 | 24.6 |
12:16 ET | 48470 | 24.45 |
12:18 ET | 13586 | 24.33 |
12:20 ET | 17397 | 24.3 |
12:21 ET | 6354 | 24.345 |
12:23 ET | 10395 | 24.2652 |
12:25 ET | 11202 | 24.3153 |
12:27 ET | 18545 | 24.44 |
12:30 ET | 12248 | 24.47 |
12:32 ET | 11196 | 24.5598 |
12:34 ET | 7069 | 24.48 |
12:36 ET | 4155 | 24.46 |
12:38 ET | 8191 | 24.53 |
12:39 ET | 10458 | 24.5392 |
12:41 ET | 6950 | 24.59 |
12:43 ET | 21015 | 24.67 |
12:45 ET | 19118 | 24.7588 |
12:48 ET | 26629 | 24.765 |
12:50 ET | 12664 | 24.72 |
12:52 ET | 3428 | 24.715 |
12:54 ET | 12764 | 24.795 |
12:56 ET | 21804 | 24.7973 |
12:57 ET | 19652 | 24.785 |
12:59 ET | 19155 | 24.875 |
01:01 ET | 10492 | 24.88 |
01:03 ET | 6089 | 24.845 |
01:06 ET | 11352 | 24.83 |
01:08 ET | 19727 | 24.79 |
01:10 ET | 11095 | 24.875 |
01:12 ET | 121513 | 25.05 |
01:14 ET | 21282 | 24.91 |
01:15 ET | 11317 | 24.9 |
01:17 ET | 27649 | 24.95 |
01:19 ET | 10050 | 24.92 |
01:21 ET | 13063 | 25.0614 |
01:24 ET | 19692 | 24.97 |
01:26 ET | 14163 | 25.02 |
01:28 ET | 8183 | 24.95 |
01:30 ET | 4317 | 24.96 |
01:32 ET | 7607 | 24.985 |
01:33 ET | 8577 | 25.02 |
01:35 ET | 5367 | 24.990133 |
01:37 ET | 7283 | 25.04 |
01:39 ET | 4848 | 25.015 |
01:42 ET | 8153 | 24.9802 |
01:44 ET | 11636 | 25 |
01:46 ET | 11667 | 25.0025 |
01:48 ET | 15317 | 25.04 |
01:50 ET | 46000 | 25.11 |
01:51 ET | 29765 | 25.14 |
01:53 ET | 15779 | 25.19 |
01:55 ET | 67379 | 25.4 |
01:57 ET | 19082 | 25.38 |
02:00 ET | 16708 | 25.36 |
02:02 ET | 17375 | 25.36 |
02:04 ET | 7661 | 25.3799 |
02:06 ET | 11938 | 25.45 |
02:08 ET | 20379 | 25.4 |
02:09 ET | 39667 | 25.36 |
02:11 ET | 20437 | 25.36 |
02:13 ET | 5179 | 25.3595 |
02:15 ET | 8200 | 25.375 |
02:18 ET | 22563 | 25.48 |
02:20 ET | 12065 | 25.43 |
02:22 ET | 15555 | 25.445 |
02:24 ET | 38539 | 25.55 |
02:26 ET | 9824 | 25.56 |
02:27 ET | 10163 | 25.61 |
02:29 ET | 29592 | 25.7 |
02:31 ET | 16869 | 25.7199 |
02:33 ET | 25111 | 25.685 |
02:36 ET | 23033 | 25.7215 |
02:38 ET | 72489 | 25.754 |
02:40 ET | 16732 | 25.73 |
02:42 ET | 21514 | 25.7699 |
02:44 ET | 55833 | 25.77 |
02:45 ET | 32350 | 25.79 |
02:47 ET | 43361 | 25.61 |
02:49 ET | 23799 | 25.6236 |
02:51 ET | 17260 | 25.62 |
02:54 ET | 28657 | 25.77 |
02:56 ET | 21952 | 25.77 |
02:58 ET | 23214 | 25.8391 |
03:00 ET | 22546 | 25.8 |
03:02 ET | 30118 | 25.75 |
03:03 ET | 29519 | 25.53 |
03:05 ET | 53799 | 25.315 |
03:07 ET | 27741 | 25.295 |
03:09 ET | 14225 | 25.39 |
03:12 ET | 22399 | 25.4036 |
03:14 ET | 16601 | 25.49 |
03:16 ET | 14725 | 25.38 |
03:18 ET | 26041 | 25.26 |
03:20 ET | 24253 | 25.23 |
03:21 ET | 22005 | 25.18 |
03:23 ET | 20194 | 25.14 |
03:25 ET | 18986 | 25.185 |
03:27 ET | 15182 | 25.14 |
03:30 ET | 13594 | 25.17 |
03:32 ET | 20662 | 25.19 |
03:34 ET | 14092 | 25.265 |
03:36 ET | 23574 | 25.22 |
03:38 ET | 16092 | 25.225 |
03:39 ET | 15715 | 25.22 |
03:41 ET | 21171 | 25.175 |
03:43 ET | 19191 | 25.18 |
03:45 ET | 18210 | 25.155 |
03:48 ET | 23875 | 25.235 |
03:50 ET | 22887 | 25.23 |
03:52 ET | 55291 | 25.135 |
03:54 ET | 37649 | 25.105 |
03:56 ET | 52748 | 24.93 |
03:57 ET | 113989 | 24.855 |
03:59 ET | 562285 | 24.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.9B | 41.5x | --- |
ADMA Biologics Inc | 4.2B | 129.4x | --- |
Axsome Therapeutics Inc | 4.4B | -14.2x | --- |
Arcellx Inc | 4.1B | -73.3x | --- |
Denali Therapeutics Inc | 4.3B | -10.6x | --- |
CRISPR Therapeutics AG | 4.1B | -14.9x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.21 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 41.5x |
Price/Sales (TTM) | 11.1 |
Price/Cash Flow (TTM) | 40.2x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.